NEW YORK (GenomeWeb) – MDx Health said today it has signed an agreement with The Netherlands' University Erasmus Medical Center (Erasmus MC) giving it exclusive worldwide rights to the use of a set of bladder cancer methylation biomarkers for clinical assay development in either the LDT or IVD setting.

The company also announced that it plans to present new top-line data on the liquid biopsy bladder cancer test it is developing with these markers at the World Congress on Urological Research meeting in September.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers in the UK and Australia uncover genetic links between BMI and depression, the Guardian reports.

The Verge details the account of an academic who alleges her university retaliated against her after she complained of sexual harassment by her supervisor.

The New York Times writes that natural history museums are helping round out genetic studies with older specimens.

In PNAS this week: artemisinin resistance mutations in malaria parasites, ant-plant interactions over time, and more.